Welcome to PHARM.D

Views:
 
Category: Education
     
 

Presentation Description

PharmD

Comments

Presentation Transcript

Welcome to Doctor of Pharmacy (PHARM.D.) PROGRAM:

Welcome to Doctor of Pharmacy (PHARM.D .) P ROGRAM PCI President Dr B Suresh who brought Doctor of Pharmacy Program to India About 62% of licensed pharmacists work in community pharmacies and 23 % work in hospitals About 71% of Pharmacy Technician jobs are in pharmacies, grocery stores, department stores, or mass retailers .

Pharm D Graduates ..?:

Pharm D Graduates ..? Pharmacy council of India started the programme in the year 2008 with a good intention to improve the pharmacy services in the Indian healthcare system and to increase the dignity of the profession. But, from the beginning a group of people have been raising allegations about the way the programme was introduced and the way it is disturbing the smooth running of the course putting the students into a quandary. http :// www.acharya.ac.in/pharmd.html

what would be job prospects for Pharm D in India ?:

what would be job prospects for Pharm D in India ? A Pharm D graduate could find jobs mostly related to the clinical force of India. With gradual amendments being made in the health care industry, the Pharm D graduate could play an active role in heading the Hospital Pharmacy Setting (Hospital Setting / Hospital Pharmacy. Also with a large number of Pharmaceutical companies opting for clinical trials the industry is heading towards a business worth 1.4 billion by way of clinical trials.

Health care system In USA:

Health care system In USA Hospital Pharmacy Community Pharmacy Clinical Pharmacy Clinical Pharmacokinetics C linical trial safety

REGISTRATION AS PHARMACIST IN INDIA AND OTHER COUNTRIES :

REGISTRATION AS PHARMACIST IN INDIA AND OTHER COUNTRIES

What kind of jobs should pharm D expect ?:

What kind of jobs should pharm D expect ?

How drugs work’s:

How drugs work’s

Future Challenges:

Future Challenges Indian Government has come out with a recommendation that ADRs should be collected for all drugs by all pharmaceutical companies, hospitals, clinician treating the patients and practicing clinicians. To take the plan forward, official sources said that MCI should be requested to take forward the process of sensitizing clinicians in the hospitals to report ADRs to the Pharmacovigilance Programme of India (PvPI). Recommendation is a part of the meeting held with the officials of the Pharmacy Council of India  and Indian Council of Medial Research (ICMR) recently.

FIPO urges govt to increase quantum of study leave to enable pharmacists to do Pharm D programme:

FIPO urges govt to increase quantum of study leave to enable pharmacists to do Pharm D programme The Federation of Indian Pharmacists Organization (FIPO) has urged the Department of Personnel & Training (DoPT), government of India to revise the Rule 51 of the Central Civil Services Leave Rules (CCS) in order to facilitate the pharmacists in the central government health services to pursue higher studies in pharmacy, especially the three-year Pharm D (PB) programme

Job Opportunities:

Job Opportunities Hospital Pharmacy Community Pharmacy Clinical Pharmacy Clinical Pharmacokinetics C linical trial safety

Job Opportunities:

Job Opportunities Pharmacovigilance Pharmaco-economics A dverse D rug R eactions (ADRs ) Clinical Research O rganizations Biostatistics and Research Methodology

Job Opportunities:

Job Opportunities Clinical Toxicology Clinical Research, Pharmacoepidemiology Pharmacotherapeutic Drug Monitoring Clinical Pharmacokinetics Pharmacoeconomics Drug Safety Forensic Pharmacy Forensic Psychology

Pharm D graduates eligible to write FRGEE in USA:

Pharm D graduates eligible to write FRGEE in USA Foreign Pharmacy Graduate Examination Committee (FPGEC )

:

Surveillance Programmes In India

CONTENTS:

CONTENTS Introduction why Pharmacovigilance Aim of Pharmacovigilance Pharmacovigilance: Future Challenges, Need & issues Outcome of successful Program in Pharmacovigilance Summery & Conclusion

PHARMACOVIGILANCE : CURRENT SCENARIO & FUTURE CHALLENGES IN INDIA:

PHARMACOVIGILANCE : CURRENT SCENARIO & FUTURE CHALLENGES IN INDIA BY V . PRAJITH

Introduction why Pharmacovigilance:

Introduction why Pharmacovigilance Pharmacovigilance Programme of India launched on July 14, 2010 is currently capturing ADR data in Indian population in a systematic way in coordination with the IPC. The main objective of the P rogramme is to monitor ADRs in Indian population. Safety Monitoring of Medicinal Products Pharmacovigilance (PV or PhV), also known as Drug Safety

Aim of Pharmacovigilance:

Aim of Pharmacovigilance All medicines have risks as well as benefits. The aim of P harmacovigilance 1 is to protect public health by identifying, evaluating, managing and minimizing safety Issues to ensure that the overall benefits of medicines outweigh the risks. Patient safety is a fundamental principle Apply computerized statistical tool s to facilitate the evaluation of safety information through, for example, the identification of unexpected adverse events that are being reported on a disproportionate basis (safety signals) The science of P harmacovigilance is continuously evolving and is actively involved in working with industry, regulators, healthcare professionals and patients to enhance methodologies in this area

Aim of Pharmacovigilance:

Aim of Pharmacovigilance Drug Technical Advisory Board (DTAB) set up Vigilance Cells F orensic P harmacy and Forensic P sychology A dverse D rug R eactions (ADRs ) Clinical Trial Safety

Outcome of successful Program in Pharmacovigilance:

Outcome of successful Program in Pharmacovigilance In this regard, IPC which acts as the national coordination centre (NCC) for Pharmacovigilance Program of India (PvPI) already had a series of strategic meetings with the Centre over the last few months . Since 2011, around 1,10,000 adverse drug reactions have been reported from across the country. However, this was after the government made it mandatory for hospitals to have a pharmacovigilance cell. Still, officials say, there are only few hospitals across the country operating with a proper cell. Currently, there are only 150 hospitals across the country which have pharmacovigilance cell, the official cell. However, the health ministry and the drug regulator are making efforts to ramp up such cells.

Surveillance Programmes:

Surveillance P rogrammes

Summery & Conclusion:

Summery & Conclusion

V.PRAJITH:

V.PRAJITH prajithkanna@gmail.com

authorStream Live Help